|
Real-time Estimate
Cboe BZX
21:19:19 30/10/2026 +03
|
5-day change | 1st Jan Change | ||
| 72.64 USD | -0.70% |
|
+0.63% | -7.44% |
| 10-22 | ANI Pharmaceuticals' Eye-Care Franchise Faces New Competition, Oppenheimer Says | MT |
| 10-19 | ANI Pharmaceuticals, Inc. Launches Duloxetine Delayed-Release Capsules | CI |
| Market Cap | 1.57B 1.4B 1.29B 1.17B 2.19B 149B 2.23B 15.4B 6.18B 78.31B 5.88B 5.76B 247B | P/E 2026 * |
14.6x | P/E 2027 * | 12.8x |
|---|---|---|---|---|---|
| Enterprise Value | 1.72B 1.54B 1.42B 1.28B 2.4B 163B 2.44B 16.88B 6.77B 85.8B 6.45B 6.31B 271B | EV / Sales 2026 * |
1.56x | EV / Sales 2027 * | 1.23x |
| Free-Float |
86.78% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ANIP | Delayed | |
CBOE
| ANIP | Real-time | |
|
Tradegate
| BSFA | Real-time | |
|
Deutsche Boerse AG
| BSFA | Delayed | |
|
Börse Stuttgart
| BSFA | Delayed | |
|
Boerse Muenchen
| BSFA | Real-time | |
|
Berne S.E.
| BSFA | End-of-day quote |
Last Transcript: ANI Pharmaceuticals, Inc.
| 1 day | -0.49% | ||
| 1 week | +0.63% | ||
| Current month | +0.58% | ||
| 1 month | +0.58% | ||
| 3 months | -9.15% | ||
| 6 months | -8.03% | ||
| Current year | -7.44% |
| 1 week | 70.31 |  | 73.84 |
| 1 month | 69.9 | | 74.43 |
| Current year | 69.58 | | 87.76 |
| 1 year | 69.58 | | 95.57 |
| 3 years | 48.2 | | 99.5 |
| 5 years | 22.31 | | 99.5 |
| 10 years | 22.31 | | 99.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Nikhil Lalwani
CEO | Chief Executive Officer | 48 | 08/09/2020 |
Stephen Carey
DFI | Director of Finance/CFO | 55 | 06/05/2016 |
Elizabeth Powell
CMP | Compliance Officer | - | 24/02/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Thomas Haughey
CHM | Chairman | 62 | 24/11/2025 |
Antonio Pera
BRD | Director/Board Member | 68 | 06/08/2020 |
Jeanne A. Thoma
BRD | Director/Board Member | 66 | 06/08/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 10/15/26 A | Sell | Chief Executive Officer | -5,400 | 0.0235% | ||
| 10/13/26 A | Sell | General Counsel | -500 | 0.0022% | ||
| 9/29/26 A | Sell | Chief Financial Officer | -2,850 | 0.0124% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.70% | +0.63% | -20.52% | +20.78% | 1.57B | |
| +3.73% | +11.90% | +68.74% | +151.90% | 1,224B | |
| +0.20% | +4.96% | +46.47% | +88.32% | 662B | |
| +1.30% | +3.58% | +29.65% | +108.52% | 514B | |
| +0.42% | +3.20% | +54.15% | +67.18% | 388B | |
| +2.60% | +3.72% | +74.63% | +46.74% | 361B | |
| +1.12% | +4.52% | +35.30% | +58.08% | 302B | |
| +6.96% | +8.86% | +11.27% | +36.62% | 271B | |
| +1.88% | +7.15% | +61.19% | +78.84% | 249B | |
| +4.12% | +10.67% | +45.80% | +122.05% | 205B | |
| Average | +2.22% | +2.25% | +40.67% | +77.90% | 417.84B | |
| Weighted average by Cap. | +2.42% | +3.04% | +51.80% | +99.40% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.1B 988M 909M 823M 1.54B 105B 1.57B 10.84B 4.35B 55.09B 4.14B 4.05B 174B | 1.22B 1.09B 1.01B 912M 1.7B 116B 1.74B 12B 4.82B 61.02B 4.58B 4.49B 192B |
| Net income | 111M 99.74M 91.75M 83.13M 155M 10.57B 158M 1.09B 439M 5.56B 418M 409M 17.54B | 128M 115M 105M 95.56M 179M 12.16B 182M 1.26B 505M 6.39B 480M 470M 20.16B |
| Net Debt | 150M 134M 124M 112M 209M 14.24B 213M 1.47B 592M 7.49B 563M 551M 23.63B | -64.92M -58.14M -53.48M -48.46M -90.58M -6.16B -92.28M -638M -256M -3.24B -244M -238M -10.23B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 30/10/26 | $73.07 | -0.12% | 76,823 |
| 29/10/26 | $73.16 | +2.02% | 262,411 |
| 28/10/26 | $71.71 | +0.76% | 335,904 |
| 27/10/26 | $71.17 | -1.97% | 285,233 |
| 26/10/26 | $72.60 | -0.01% | 229,290 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ANIP Stock
Select your edition
All financial news and data tailored to specific country editions
